Article Data

  • Views 206
  • Dowloads 130

Original Research

Open Access

Stage I ovarian cancer: Comparison of laparoscopy and laparotomy on staging and survival

  • F. Lecuru1,*,
  • P. Desfeux1
  • S. Camatte1
  • A. Bissery2
  • F. Robin1
  • B. Blanc3
  • D. Querleu4

1Service de Chirurgie Gynecologique et Cancerologique, Hopital Europeen Georges Pompidou, Faculte de Medecine Necker Enfants Malades, Paris

2Centre Investigation Clinique, Hopital Europeen Georges Pompidou, Paris

3Matemite de la Conception, Marseille

4Centre Claudius Regaud, Toulouse, France

DOI: 10.12892/ejgo200405571 Vol.25,Issue 5,September 2004 pp.571-576

Published: 10 September 2004

*Corresponding Author(s): F. Lecuru E-mail:

Abstract

Objective: The aim of this study was to compare staging accurateness as well as survival when managing early ovarian cancers by laparoscopy or laparotomy.

Material and methods: We have conducted a retrospective and multicentric study in France. Only Stage I ovarian epithelial cancers operated on from January 1, 1985 to December 31, 1999 were taken into account. Respondents had to fill in a form detailing in each case the surgical access; the surgical acts performed during the initial intervention as well as data on the patient's follow-up. Lack of follow-up or final Stage > I were considered as exclusion criteria. Data were recorded and analysed with SPSS 7.5 and STATA (Stata statistical sofware 7.0). (ANOVA, chi-square test or Fisher's exact test and log-rank test).

Results: 105 cases were included: 14 patients were exclusively operated on by laparoscopy (group 1), 13 other patients were subjected to a conversion from laparoscopy to laparotomy (group 2) and 78 patients exclusively underwent laparotomy (group 3). Patients in group 3 were significantly more frequently postmenopausal and had larger lesions. Cyst rupture was rare during laparoscopy (21%) and the use of an endobag was achieved in only 21% of the patients in group 1. Radical treatment was significantly more frequent in group 3 when compared to group 1 (67% vs 23%, p < 0.05). Laparoscopy was not adequate for staging since no lymphadenectomy was carried out by this approach. However, only 27% of patients subjected to an open approach underwent lymphadenectomy and omentectomy. The outcome in terms of survival was similar in the three groups with a mean follow-up period of 1,221 days (+/- 832) (p = 0.1).

Conclusion: Laparoscopic management of early ovarian cancer is poorly efficient in staging although disease-free survival does not seem to be affected. Further evaluation of laparoscopy in this indication is needed.

Keywords

Ovarian cancer; Stage I; Laparoscopy; Laparotomy; Staging; Survival

Cite and Share

F. Lecuru,P. Desfeux,S. Camatte,A. Bissery,F. Robin,B. Blanc,D. Querleu. Stage I ovarian cancer: Comparison of laparoscopy and laparotomy on staging and survival. European Journal of Gynaecological Oncology. 2004. 25(5);571-576.

References

[1] Canis M., Botschorishvili R., Manhes H., Wattiez A., Mage G., Pouly J.L., Bruhat M.A.: "Management of adnexal masses: role and risk of laparoscopy". Seminars Surg. Oncol., 2000, 19, 28.

[2] Yuen P., Yu K., Yip S., Lau W., Rogers M., Chang A.: "A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses". Am. J. Obstet. Gynecol. 1997, 177, 109.

[3] Querleu D., Leblanc E.: "Laparoscopic infrarenal paraaortic lymph node dissection for restaging of carcinoma of the ovary or fallopian tube". Cancer, 1994, 73, 1467.

[4] Possover M., Krause N., Plaul K.. Klihne-Heid R., Schneider A.; "Laparoscopic paraaortic and pelvic lymphadenectomy: experience with 150 patients and review of literature". Gynecol. Oneal., 1998,71, 19.

[5] Scribner D.. Walker J.. Jonhson G., McMeekin S., Gold M., Mannel R.: "Laparoscopic and paraaortic lymph node dissection analysis of the first 100 cases". Gynecol. Oneal., 2001, 82, 498.

[6] Pomel C., Provencher D., Dauplat J., Gauthier P., Le Bouedec G., Drouin P. et al.: "Laparoscopic staging of early ovarian cancer" Gynecol. Oneal., 1995, 58, 301.

[7] Young R., Decker D., Wharton T., Piver S., Sindelar W., Edwards B., Smith J.: "Staging laparotomy in early ovarian cancer". JAMA, 1983, 250, 3072.

[8] Le T., Adolph A., Krepart G., Lotocki R., Heywood M.: "The benefits of comprehensive surgical staging in the management of early stage epithelial ovarian carcinoma". Gynecol. Oneal., 2002, 85, 351.

[9] Mathew G., Watson D., Rofe A., Ellis T., Jamieson G.: "Advers impact of pneumoperitoneum on intraperitoneal implantation and growth of tumour cell suspension in an experimental model". Aust. N. Z. J. Surg., 1997, 67, 289.

[10] Lehner R.,W enzl R.,H einzl H., Husslein P.,S evelda P.: "Influence of delayed staging laparotomy after laparoscopic removal of ovarian masses later found malignant". Obstet. Gynecol., 1998, 92, 967

[11] Blanc B., Boubli L., D'Ercole L., Nicoloso E.: "Laparoscopic management of malignant ovarian cysts: A 78 cases national survey. Part 1: pre-operative and laparoscopic evaluation". Eur. J. Obstet. Gynecol. Biol. Reprod., 1994, 56, 177.

[12] Maiman M., Seltzer V., Boyce J.: "Laparoscopic excision of ovarian neoplasms subsequently found to be malignant". Obstet Gynecol., 1991, 77, 565.

[13] Wang P., Luan C., Lin G., Ng H., Chao H.: "Risks factors contributing to early occurrence of portsite metastases of laparoscopic surgery for malignancy". Gynecol. Oneal., 1999, 72, 38.

[14] Leminen A., Lehtovirta P.: "Spread of ovarian cancer after laparoscopic surgery: report of eight cases". Gynecol. Oneal., 1999, 75, 387.

[15] Leblanc E., Querleu D., Narducci F., Chauvet M.P., Chevalier A., Lesoin A. et al.: "Surgical staging of early invasive epithelial ovarian tumors". Seminars Surg. Oneal., 2000, 19, 36.

[16] Vergote I., De Brabanter J., Fyles A., Beterlsen K., Einhorn N., Sevelda P. et al.: "Prognostic importance of degree of differentiation and cyst rupture in Stage I invasive epithelial ovarian carcinoma". Lancet, 2001, 357, 176.

[17] Jacobi C., Wildbrett P., Volk T., Miiller J.M.: "Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model". Surg. Endosc., 1999, 13, 1021.

[18] YoshinakaA., Fukasawa I.,S akamoto T.,T anaka M., Ota Y., Inaba N.:'The fertility and pregnancy outcomes of the patients who underwent preservative operation followed by adjuvant chemotherapy for malignant ovarian tumors". Arch. Gynecol. Obstet., 2000, 264, 124.

[19] Morice P., Wicart-Poque F., Rey A., El- Hassan J., Pautier P., Lhomme C. et al.: "Results of conservative treatment in epithelial ovarian carcinoma". Cancer, 2001, 92, 2412.

[20] Burghardt E., Girardi F.,L ahousen M., Tamussino K.,S tettner H.: "Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer". Gynecol. Oneal., 1991, 40, 103.

[21] Benedetti-Panici P.,M aneschi F.,S cambia G., Greggi S.,M ancuso S.: "Anatomic abnormalities of the retroperitoneum encountered during aortic and pelvic lymphadenectomy". Obstet. Gynecol., 1993, 170, 111.

[22] Petru E., Lahousen M., Tamussino K., Pickel H., Stranzl H., Stettner H., Winter R.: "Lymphadenectomy in Stage I ovarian cancer" Am. J. Obstet. Gynecol., 1994, 170, 656.

[23] Le Bouedec G., Fondrinier E., Kauffman P., Mansoor A., Dauplat J.: "Pelvic and paraortic lymphadenectomy in ovarian cancer" Presse Med., 1992, 21, 745.

[24] Cass I., Li A., Runowicz C., Fields A., Goldberg G., Leuchter R et al.: "Pattern of lymph node metastases in clinically unilateral Stage I invasive epithelial ovarian carcinomas". Gynecol. Oncol., 2001, 80, 56.

[25] Childers J., Lang J., Surwitt E., Hatch K.: "Laparoscopic surgical staging of ovarian cancer". Gynecol. Oncol., 1995, 59, 25.

[26] Schlaert J.B., Spirtos N., Carson L., Boike G., Adamek T., Stonebaker B.: "Laparoscopic retroperitoneal lymphadenectomy in women with cervical cancer: A gynecologic oncology group study". Gynecol. Oncol., 2002, 85, 81.

[27] Soper J., Johnson P., Johnson V.: "Comprehensive restagmg laparotomy in women with apparent early ovarian carcinoma". Obstet. Gynecol., 1992, 80, 949.

[28] Stier E., Barakat R., Curtin J.: "Laparotomy to complete staging of presumed early ovarian cancer". Obstet. Gynecol., 1996, 87, 737.

[29] Finn C., Luesley D., Buxton E., Blackledge G., Kelly K., Dunn J., Wilson S.: "Is Stage I epithelial ovarian cancer overtreated both surgically and systematically? Results of a five year cancer registry review". Br. J. Obstet. Gynaecol., 1992, 99, 54.

[30] Le T., Krepart G.V., Lotocki R.J., Heywood M.S.: "Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly?". Gynecol. Oneal., 1999, 74, 252.

[31] Gutlrrie D., Davy M.L., P hilips P.R.: "A study of 656 patients with early ovarian cancer". Gynecol. Oneal., 1984, 17, 363.

[32] Ahmed F., Wiltshaw E., A'Hern R., Nicol B., Shepherd J., Blake P. et al.: "Natural history and prognosis of untreated stage I epithelial ovarian cancer". J. Clin. Oneal., 1996, 14, 2968.

[33] Lecuru F., Agostini A., Camatte S., Robin F., Aggerbeck M., Jais J.P et al.: "Impact of pneumoperitoneum on visceral metastasis rate and survival". Br. J. Obstet. Gynaecol., 2001, 108, 733.

[34] Fowler J., Carter J., Carlson J., Maslonkovski R., Byers L., Carson F., Twiggs L.: "Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study". Gynecol. Oneal., 1993, 51, 187.

[35] Childers J., Nasseri A., Surwitt E.: "Laparoscopic management of suspicious adnexal masses". Am. J. Obstet. Gynecol., 1996, 175, 1451.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top